The present disclosure relates to highly resistant starch compositions, methods for preparing such highly resistant starch compositions, and methods of using such highly resistant starch compositions to treat or prevent a disease or condition associated with dysregulation and/or dysfunction of the intestinal microbiome.

A method is provided of manufacturing a biodegradable healthcare product for environmental purposes such as reducing waste. The main ingredients include a quantity of potato starch, a quantity of corn starch, and a quantity of avocado seeds. The quantity of potato starch, the quantity of corn starch, and the quantity of avocado seeds are all pulverized. The quantity of potato starch, the quantity of corn starch, and the quantity of avocado seeds are amalgamated into a quantity of biodegradable powder. A molding process is executed by manufacturing a sterile healthcare product from the quantity of biodegradable powder. The sterile healthcare product can be any type of healthcare product such as, but not limited to, a pharmaceutical product bottle, a nutraceutical product bottle, a one test kit container, a band-aid container, a dental floss container, a swab container, a syringe, an inhaler, a dropper, or a tampon.

The invention is directed to a method of preparing a milk substitute from starch and protein that are first isolated from a root, tuber, cereal, nut or legume. The method comprises preparing an emulsion comprising at least 0.3 wt. % of emulsifying agent (modified starch and optionally native protein), at least 0.2 wt. % denatured protein, at least 1.0 wt. % of lipid. By first isolating the starch and protein from the plant source and then at a later step recombining these in the desired form and quantities, the invention el allows for more control of the final composition and organoleptic properties of the milk substitute.

The invention is directed to a method of preparing a milk substitute from starch and protein that are first isolated from a root, tuber, cereal, nut or legume. The method comprises preparing an emulsion comprising at least 0.3 wt. % of emulsifying agent (native protein and optionally emulsifying starch), at least 0.2 wt. % denatured protein, and at least 1.0 wt. % of lipid. By first isolating the starch and protein from the plant source and then at a later step recombining these in the desired form and quantities, the invention allows for more control of the final composition and organoleptic properties of the milk substitute.

Materials and methods for making plants (e.g., Solanum varieties) with decreased levels of amylose are provided herein. The methods can include making mutations in the gene encoding granule bound starch synthase (GBSS), where the mutations are induced using a rare-cutting endonuclease.

A method is provided of manufacturing a biodegradable healthcare product for environmental purposes such as reducing waste. The main ingredients include a quantity of potato starch, a quantity of corn starch, and a quantity of avocado seeds. The quantity of potato starch, the quantity of corn starch, and the quantity of avocado seeds are all pulverized. The quantity of potato starch, the quantity of corn starch, and the quantity of avocado seeds are amalgamated into a quantity of biodegradable powder. A molding process is executed by manufacturing a sterile healthcare product from the quantity of biodegradable powder. The sterile healthcare product can be any type of healthcare product such as, but not limited to, a pharmaceutical product bottle, a nutraceutical product bottle, a one test kit container, a band-aid container, a dental floss container, a swab container, a syringe, an inhaler, a dropper, or a tampon.